ARCT•benzinga•
Canaccord Genuity Maintains Buy on Arcturus Therapeutics, Lowers Price Target to $68
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 10, 2025 by benzinga